My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT

Galectin Therapeutics Stock Investors

Based on 520,949 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GALT
On average, investors allocate 2.96% of their portfolios to GALT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 520,949 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GALT

2.2%
Last 7
Days
3.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GALT, out of 520,949 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GALT Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Closed
0.00%
$3.27
Closed
0.00%
$3.17
Closed
0.00%
$4.15
Based on the activity of 43,908 investors who made their portfolios public
The table shows changes in GALT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GALT Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ATNMActinium Pharmaceuticals
7.20%
-3.10%
-3.60%
$163.03M
Healthcare
SRNESorrento Therapeutics
6.92%
0.36%
-4.32%
$1.83B
Healthcare
BLRXBiolinerx
5.56%
-9.69%
-12.34%
$125.30M
Healthcare
KALAKala Pharmaceuticals
4.37%
-1.16%
-0.83%
$107.63M
Healthcare
GLMDGalmed Pharmaceuticals
4.65%
-2.48%
-2.06%
$53.63M
Healthcare
AQSTAquestive Therapeutics
7.72%
-0.30%
2.95%
$244.20M
Healthcare
MBRXMoleculin Biotech
4.00%
-1.15%
-3.32%
$62.87M
Healthcare
LCTXLineage Cell Therapeutics
6.68%
1.59%
3.51%
$364.09M
Healthcare
VKTXViking Therapeutics
4.99%
0.40%
-3.03%
$443.59M
Healthcare
XERSXeris Pharmaceuticals
4.44%
-0.62%
-7.38%
$273.11M
Healthcare
Based on the activity of 520,949 active portfolios
Open your Smart Portfolio

GALT Investor Analysis

GALT investors under 35

Under 35

2.6%
Last 30 days
Holdings Change
8.3%
of GALT holders
are under 35
Average Segment Performance
Monthly Return1.29%
Beta1.41
Dividend Yield6.51%
GALT investors between 35–55

Between 35–55

19.8%
Last 30 days
Holdings Change
62.5%
of GALT holders
are between 35–55
Average Segment Performance
Monthly Return1.44%
Beta5.44
Dividend Yield24.36%
GALT investors over 55

Over 55

13.9%
Last 30 days
Holdings Change
29.2%
of GALT holders
are over 55
Average Segment Performance
Monthly Return1.42%
Beta1.27
Dividend Yield6.84%
Overview of age group and performance of GALT stock investors
See who invests in GALT according to age group and performance.

Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
ENTBFEntheon Biomedical
MCURFMind Cure Health
SEHCFSweet Earth Holdings
BTTXMountain Crest Acquisition II
DNAGinkgo Bioworks Holdings

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis